Kontrastmittelinduzierte Nephropathie

Schlüsselwörter

Nephropathie - Röntgen-Kontrastmittel - Prävention - Acetylcystein

Keywords

contrast-induced nephropathy - CIN - prevention - acetylcysteine

• Literatur

• 1 ACT Investigators. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT). Circulation 2011; 124: 1250-1259
• 2 Briguori C, Visconti G, Focaccio A et al. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury. Circulation 2011; 124: 1260-1269
• 3 Cely CM, Schein RM, Quartin AA. Risk of contrast induced nephropathy in the critically ill: a prospective, case matched study. Crit Care 2012; 16: R67
• 4 Cho A, Lee JE, Yoon JY et al. Effect of an electronic alert on risk of contrast-induced acute kidney injury in hospitalized patients undergoing computed tomography. Am J Kidney Dis 2012; 60: 74-81
• 5 Cruz DN, Goh CY, Marenzi G et al. Renal replacement therapies for prevention of radiocontrast-induced nephropathy: a systematic review. Am J Med 2012; 125: 66-78
• 6 Er F, Nia AM, Dopp H et al. Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro Trial (Renal Protection Trial). Circulation 2012; 126: 296-303
• 7 Fliser D, Laville M, Covic A et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: Part 1: Definitions, conservative management and contrast-induced nephropathy. Nephrol Dialysis Transplant 2012; 27: 4263-4272
• 8 From AM, Bartholmai BJ, Williams AW et al. Sodium bicarbonate is associated with an increased incidence of contrast nephropathy: a retrospective cohort study of 7977 patients at mayo clinic. Clin J Amer Soc Nephrol 2008; 3: 10-18
• 9 Jneid H, Anderson JL, Wright RS et al. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/Non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology. Circulation 2012; 126: 875-910
• 10 Kunadian V, Zaman A, Spyridopoulos I et al. Sodium bicarbonate for the prevention of contrast induced nephropathy: a meta-analysis of published clinical trials. Europ JRadiol 2011; 79: 48-55
• 11 Maioli M, Toso A, Leoncini M et al. Persistent renal damage after contrast-induced acute kidney injury: incidence, evolution, risk factors, and prognosis. Circulation 2012; 125: 3099-3107
• 12 Marenzi G, Ferrari C, Marana I et al. Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial. JACC Cardiovasc Intervent 2012; 5: 90-97
• 13 Navaneethan SD, Singh S, Appasamy S et al. Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis. Am J Kidney Dis 2009; 53: 617-627
• 14 POSEIDON. Hydration based on ventricular pressure is effective in reducing kidney damage in patients undergoing cardiac catheterization. http://www.tctconference.com/component/content/article.html?id=570
• 15 Sgura FA, Bertelli L, Monopoli D et al. Mehran contrast-induced nephropathy risk score predicts short- and long-term clinical outcomes in patients with ST-elevation-myocardial infarction. Circulation Cardiovascular Intervent 2010; 3; 491-498
• 16 Wijns W, Kolh P, Danchin N et al. Guidelines on myocardial revascularization. Europ Heart J 2010; 31: 2501-2555